Autolus Therapeutics Stock Technical Analysis
| AUTL Stock | USD 3.27 0.17 5.48% |
As of the 29th of November, Autolus Therapeutics shows the Standard Deviation of 4.75, mean deviation of 3.53, and Risk Adjusted Performance of (0.02). Autolus Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Autolus Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Autolus Therapeutics is priced correctly, providing market reflects its regular price of 3.27 per share. Given that Autolus Therapeutics has information ratio of (0.06), we suggest you to validate Autolus Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.
Autolus Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Autolus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AutolusAutolus |
Autolus Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 8.2 | Strong Buy | 10 | Odds |
Most Autolus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Autolus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Autolus Therapeutics, talking to its executives and customers, or listening to Autolus conference calls.
Autolus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Autolus Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Autolus Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Autolus Therapeutics Trend Analysis
Use this graph to draw trend lines for Autolus Therapeutics. You can use it to identify possible trend reversals for Autolus Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Autolus Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Autolus Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Autolus Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Autolus Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 8.38, which is the sum of squared deviations for the predicted Autolus Therapeutics price change compared to its average price change.About Autolus Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Autolus Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Autolus Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Autolus Therapeutics price pattern first instead of the macroeconomic environment surrounding Autolus Therapeutics. By analyzing Autolus Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Autolus Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Autolus Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 10.65 | 9.02 | 225.06 | 213.81 | PTB Ratio | 1.19 | 0.6 | 10.05 | 6.27 |
Autolus Therapeutics November 29, 2024 Technical Indicators
Most technical analysis of Autolus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Autolus from various momentum indicators to cycle indicators. When you analyze Autolus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.53 | |||
| Coefficient Of Variation | (2,869) | |||
| Standard Deviation | 4.75 | |||
| Variance | 22.56 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 26.03 | |||
| Value At Risk | (7.83) | |||
| Potential Upside | 6.49 | |||
| Skewness | (0.25) | |||
| Kurtosis | 1.53 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Autolus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Autolus Stock please use our How to buy in Autolus Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autolus Therapeutics. If investors know Autolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Autolus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share 0.043 | Quarterly Revenue Growth 6.81 | Return On Assets (0.22) | Return On Equity (0.82) |
The market value of Autolus Therapeutics is measured differently than its book value, which is the value of Autolus that is recorded on the company's balance sheet. Investors also form their own opinion of Autolus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Autolus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Autolus Therapeutics' market value can be influenced by many factors that don't directly affect Autolus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Autolus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Autolus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Autolus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.